Boston Diagnostic Aphasia Examination
| Boston Diagnostic Aphasia Examination | |
|---|---|
| Purpose | Assessment of aphasia |
The Boston Diagnostic Aphasia Examination (BDAE) is a comprehensive tool used to evaluate a wide range of language impairments associated with aphasia. Developed by Harold Goodglass and Edith Kaplan, the BDAE is designed to assess the presence and type of aphasia, as well as the severity of the condition. It is widely used in clinical settings to help diagnose language disorders resulting from brain damage, such as that caused by stroke or traumatic brain injury.
History[edit | edit source]
The BDAE was first published in 1972 and has undergone several revisions to improve its accuracy and applicability. The test was developed at the Boston Veterans Administration Medical Center and has become one of the most widely used aphasia assessments in the world.
Structure[edit | edit source]
The BDAE consists of a series of subtests that evaluate different aspects of language function, including:
Each subtest is designed to assess specific language abilities, allowing clinicians to identify patterns of impairment that correspond to different types of aphasia, such as Broca's aphasia, Wernicke's aphasia, and Global aphasia.
Administration[edit | edit source]
The BDAE is typically administered by a trained speech-language pathologist and can take several hours to complete, depending on the patient's level of impairment. The test is scored based on the patient's performance in each subtest, and the results are used to determine the type and severity of aphasia.
Interpretation[edit | edit source]
The results of the BDAE provide a detailed profile of the patient's language abilities, which can be used to guide treatment planning and monitor progress over time. The test is particularly useful for distinguishing between different types of aphasia and for identifying specific areas of language impairment that may benefit from targeted therapy.
Also see[edit | edit source]
- Aphasia
- Broca's aphasia
- Wernicke's aphasia
- Global aphasia
- Speech-language pathology
- Neuropsychological assessment
| Neuropsychology |
|---|
 |
|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
